Ensysce Biosciences, Inc.

ENSC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Aug 30, 2024
424B5 Aug 29, 2024
424B5 Aug 29, 2024
8-K Aug 23, 2024
8-K Aug 14, 2024
10-Q Aug 14, 2024
8-K May 28, 2024
8-K May 13, 2024
10-Q May 13, 2024
8-K May 9, 2024
EFFECT May 1, 2024
POS AM Apr 19, 2024
EFFECT Apr 5, 2024
CORRESP Apr 3, 2024
8-K Mar 29, 2024
S-1/A Mar 26, 2024
8-K Mar 15, 2024
10-K Mar 15, 2024
D Feb 21, 2024
424B3 Feb 15, 2024
8-K Feb 14, 2024
SC 13G/A Feb 14, 2024 SCHEDULE 13G/A
424B3 Feb 14, 2024
UPLOAD Jan 22, 2024
S-1 Jan 17, 2024
← Newer Page 5 of 22 · 546 filings Older →